logo
logo

Vector Bio Med Appoints Jakob Reiser, Ph.D., As Senior Director of Regulatory Affairs

Apr 11, 2023over 2 years ago

Position

Senior Director Of Regulatory Affairs

Company

Vector Biomed

Jakob Reiser
GaithersburgOther

Description

Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced the appointment of Jakob Reiser, Ph.D., to the position of Senior Director, Regulatory Affairs, as the Company expands its team to offer a best-in-class lentiviral vector platform to aid in the development of innovative gene therapies. Dr. Reiser brings more than 45 years of scientific and regulatory experience to Vector BioMed including nearly 15 years as a principal investigator at the Center for Biologics Evaluation and Research , part of the U.S

Company Information

Company

Vector Biomed

Location

910 CLOPPER RD., STE 200S

Gaithersburg, Maryland, United States

About

Vector BioMed is a state-of-the-art vector contract development and manufacturing organization (CDMO) specializing in best-in-class lentiviral vectors to increase efficiencies in clinical development and commercialization of cell and gene therapies. Vector BioMed's services include turn-key solutions for vector design, vector optimization, pre-clinical manufacturing, and GMP manufacturing to address the industry's current vector supply bottleneck by providing high-titer lentiviral vectors from bench to clinic to commercialization. Vector BioMed is the first company to be originated by Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all patients. For more information on Vector BioMed visit https://vectorbiomed.com/.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months